Back to search
Recurrent Atypical/malignant Meningioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Atypical/malignant Meningioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Atypical/malignant Meningioma trials you may qualify forThe primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the maxi…
The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field therap…
Apatinib mesylate may be an effective treatment for recurrent atypical/malignant meningioma. This prospective clinical study is now planned to verify the effect…
The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard t…
This research study is studying targeted immunotherapies as a possible treatment for recurrent meningioma. The names of the study interventions involved in this…